Zhang X - Search Results

1

Activating Wnt/β-catenin signaling pathway for disease therapy: Challenges and opportunities.

Huang P, Yan R, Zhang X, Wang L, Ke X, Qu Y. Huang P, et al. Among authors: zhang x. Pharmacol Ther. 2019 Apr;196:79-90. doi: 10.1016/j.pharmthera.2018.11.008. Epub 2018 Nov 20. Pharmacol Ther. 2019. PMID: 30468742 Review.

2

Targeting the β-catenin signaling for cancer therapy.

Zhang X, Wang L, Qu Y. Zhang X, et al. Pharmacol Res. 2020 Oct;160:104794. doi: 10.1016/j.phrs.2020.104794. Epub 2020 Apr 8. Pharmacol Res. 2020. PMID: 32278038 Review.

3

A TCM Formula YYWY Inhibits Tumor Growth in Non-Small Cell Lung Cancer and Enhances Immune-Response Through Facilitating the Maturation of Dendritic Cells.

Zhao B, Hui X, Jiao L, Bi L, Wang L, Huang P, Yang W, Yin Y, Jin S, Wang C, Zhang X, Xu L. Zhao B, et al. Among authors: zhang x. Front Pharmacol. 2020 Jun 9;11:798. doi: 10.3389/fphar.2020.00798. eCollection 2020. Front Pharmacol. 2020. PMID: 32595493 Free PMC article.

4

Small molecule targeting topoisomerase 3β for cancer therapy.

Zhang X, Wang L, Zhang Q, Lyu S, Zhu D, Shen M, Ke X, Qu Y. Zhang X, et al. Among authors: zhang q. Pharmacol Res. 2021 Dec;174:105927. doi: 10.1016/j.phrs.2021.105927. Epub 2021 Nov 2. Pharmacol Res. 2021. PMID: 34740818

5

Small Molecule Palmatine Targeting Musashi-2 in Colorectal Cancer.

Zhang X, Su K, Liu Y, Zhu D, Pan Y, Ke X, Qu Y. Zhang X, et al. Front Pharmacol. 2022 Jan 27;12:793449. doi: 10.3389/fphar.2021.793449. eCollection 2021. Front Pharmacol. 2022. PMID: 35153752 Free PMC article.

6

Towards key scientific questions in the diagnosis and treatment of rare diseases: Summary from the 297th Meeting of the Shuangqing Forum.

Zhu CY, Hong W, Wang L, Ding LJ, Zhang X. Zhu CY, et al. Among authors: zhang x. Zool Res. 2022 Mar 18;43(2):234-236. doi: 10.24272/j.issn.2095-8137.2022.068. Zool Res. 2022. PMID: 35194981 Free PMC article. No abstract available.

7

GPR108 is required for gambogic acid inhibiting NF-κB signaling in cancer.

Lyu S, Zhang X, Tu Z, Zhou H, Ke X, Qu Y. Lyu S, et al. Among authors: zhang x. Pharmacol Res. 2022 Aug;182:106279. doi: 10.1016/j.phrs.2022.106279. Epub 2022 Jun 2. Pharmacol Res. 2022. PMID: 35659621

8

Activation of CYP3A by Accelerated Blood Clearance Phenomenon Potentiates the Hepatocellular Carcinoma-Targeting Therapeutic Effects of PEGylated Anticancer Prodrug Liposomes.

Zhang X, Pan J, Ye X, Chen Y, Wang L, Meng X, Chen W, Wang F. Zhang X, et al. Drug Metab Dispos. 2023 Dec;51(12):1651-1662. doi: 10.1124/dmd.123.001496. Epub 2023 Sep 29. Drug Metab Dispos. 2023. PMID: 37775330

9

Small molecule activates citrullination through targeting PAD2.

Zhang X, Shen M, Zhu H, Zhang J, Yang M, Su K, Zhang Y, Fu W, Ke X, Qu Y. Zhang X, et al. Among authors: zhang j, zhang y. Philos Trans R Soc Lond B Biol Sci. 2023 Nov 20;378(1890):20220248. doi: 10.1098/rstb.2022.0248. Epub 2023 Oct 2. Philos Trans R Soc Lond B Biol Sci. 2023. PMID: 37778388 Free PMC article.

10

Time-dependent proteomics and drug response in expanding cancer cells.

Pan Y, Xuan Y, Hao P, Chen X, Yan R, Zhang C, Ke X, Qu Y, Zhang X. Pan Y, et al. Among authors: zhang c, zhang x. Pharmacol Res. 2024 Jun;204:107208. doi: 10.1016/j.phrs.2024.107208. Epub 2024 May 9. Pharmacol Res. 2024. PMID: 38729587 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

181,409 results

Search Page

Filters